Peter Kasper

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop

David Kirkland, Stefan Pfuhler, David Tweats et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2007 · 437 citations

Pharmacy, Toxicology, Good Laboratory Practice +12

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 406 citations

Medicine, Nephrology, Precision Medicine +13

Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests

David Kirkland, Peter Kasper, Hans‐Jörg Martus et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2015 · 180 citations · Full text

Pharmacy, Toxicology, Diagnostic Toxicology +16

Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: A follow-up to an ECVAM workshop

David Kirkland, Peter Kasper, Lutz Müller et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2008 · 172 citations

Pharmacy, Toxicology, Environmental Toxicology +12

Towards consensus practices to qualify safety biomarkers for use in early drug development

Frank D. Sistare, Frank Dieterle, Sean P. Troth et al. · Nature Biotechnology · 2010 · 121 citations

Pharmacy, Pharmacology, Regulatory Pharmacy +16